Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 15 | 2022 | 116 | 2.460 |
Why?
|
| Catheter Ablation | 11 | 2021 | 57 | 1.510 |
Why?
|
| Pacemaker, Artificial | 6 | 2022 | 15 | 1.020 |
Why?
|
| Atrial Appendage | 3 | 2020 | 29 | 0.910 |
Why?
|
| Pulmonary Veins | 5 | 2020 | 19 | 0.840 |
Why?
|
| Cardiac Pacing, Artificial | 6 | 2022 | 16 | 0.800 |
Why?
|
| Cardiac Catheterization | 2 | 2018 | 52 | 0.740 |
Why?
|
| Heart Transplantation | 1 | 2018 | 29 | 0.610 |
Why?
|
| Cryosurgery | 3 | 2020 | 21 | 0.510 |
Why?
|
| Heart Failure | 3 | 2020 | 139 | 0.440 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2020 | 59 | 0.420 |
Why?
|
| Bundle of His | 3 | 2022 | 9 | 0.420 |
Why?
|
| Electric Injuries | 1 | 2011 | 1 | 0.380 |
Why?
|
| Intercostal Muscles | 1 | 2011 | 3 | 0.380 |
Why?
|
| Spasm | 1 | 2011 | 2 | 0.380 |
Why?
|
| Treatment Outcome | 11 | 2021 | 3204 | 0.340 |
Why?
|
| Transposition of Great Vessels | 2 | 2008 | 2 | 0.330 |
Why?
|
| Heart Defects, Congenital | 1 | 2008 | 22 | 0.300 |
Why?
|
| Humans | 28 | 2022 | 25165 | 0.300 |
Why?
|
| Defibrillators, Implantable | 2 | 2018 | 9 | 0.270 |
Why?
|
| Electric Countershock | 1 | 2005 | 9 | 0.250 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2021 | 31 | 0.250 |
Why?
|
| Registries | 3 | 2021 | 173 | 0.230 |
Why?
|
| Heart Rate | 3 | 2020 | 106 | 0.230 |
Why?
|
| Male | 15 | 2021 | 13815 | 0.230 |
Why?
|
| Heart Ventricles | 2 | 2022 | 81 | 0.230 |
Why?
|
| Aged | 10 | 2021 | 8448 | 0.210 |
Why?
|
| Anticoagulants | 2 | 2018 | 81 | 0.210 |
Why?
|
| Prosthesis Implantation | 2 | 2016 | 24 | 0.200 |
Why?
|
| Electrocoagulation | 1 | 2022 | 10 | 0.200 |
Why?
|
| Atrial Flutter | 3 | 2011 | 4 | 0.200 |
Why?
|
| Equipment Design | 2 | 2021 | 132 | 0.200 |
Why?
|
| Risk Assessment | 5 | 2020 | 578 | 0.200 |
Why?
|
| Action Potentials | 2 | 2020 | 84 | 0.190 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2021 | 7 | 0.190 |
Why?
|
| Bradycardia | 1 | 2021 | 24 | 0.190 |
Why?
|
| Metabolic Equivalent | 1 | 2020 | 4 | 0.180 |
Why?
|
| Septal Occluder Device | 1 | 2020 | 7 | 0.180 |
Why?
|
| Exercise Tolerance | 1 | 2020 | 28 | 0.170 |
Why?
|
| Radiation Exposure | 1 | 2020 | 8 | 0.170 |
Why?
|
| Radiography, Interventional | 1 | 2020 | 16 | 0.170 |
Why?
|
| Radiation Dosage | 1 | 2020 | 38 | 0.170 |
Why?
|
| Middle Aged | 11 | 2020 | 8303 | 0.160 |
Why?
|
| Punctures | 1 | 2018 | 11 | 0.160 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2011 | 30 | 0.160 |
Why?
|
| Anastomosis, Surgical | 1 | 2018 | 26 | 0.160 |
Why?
|
| Electrodes, Implanted | 2 | 2008 | 20 | 0.150 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 45 | 0.150 |
Why?
|
| Time Factors | 5 | 2021 | 1336 | 0.150 |
Why?
|
| Ventricular Fibrillation | 2 | 2016 | 11 | 0.150 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2018 | 2 | 0.150 |
Why?
|
| Adult | 6 | 2021 | 7259 | 0.150 |
Why?
|
| Computer Security | 1 | 2018 | 6 | 0.150 |
Why?
|
| Azygos Vein | 1 | 2017 | 2 | 0.140 |
Why?
|
| Incidental Findings | 1 | 2017 | 12 | 0.140 |
Why?
|
| Vena Cava, Inferior | 1 | 2017 | 8 | 0.140 |
Why?
|
| Recurrence | 4 | 2020 | 274 | 0.140 |
Why?
|
| Female | 12 | 2021 | 14161 | 0.130 |
Why?
|
| Exercise | 1 | 2020 | 429 | 0.130 |
Why?
|
| Risk Factors | 6 | 2020 | 2179 | 0.130 |
Why?
|
| Intraoperative Care | 1 | 2016 | 41 | 0.130 |
Why?
|
| Retrospective Studies | 6 | 2021 | 3185 | 0.130 |
Why?
|
| Stroke | 3 | 2011 | 245 | 0.100 |
Why?
|
| Heart Atria | 1 | 2011 | 24 | 0.090 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2011 | 9 | 0.090 |
Why?
|
| Stroke Volume | 2 | 2021 | 45 | 0.090 |
Why?
|
| Thrombosis | 1 | 2011 | 51 | 0.090 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2010 | 10 | 0.090 |
Why?
|
| Telemetry | 1 | 2010 | 9 | 0.090 |
Why?
|
| Ischemic Attack, Transient | 1 | 2010 | 16 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2021 | 208 | 0.090 |
Why?
|
| Coronary Occlusion | 1 | 2010 | 1 | 0.090 |
Why?
|
| Fluoroscopy | 2 | 2020 | 43 | 0.080 |
Why?
|
| Exercise Test | 2 | 2020 | 111 | 0.080 |
Why?
|
| Coronary Angiography | 2 | 2010 | 70 | 0.080 |
Why?
|
| Brain Ischemia | 1 | 2010 | 59 | 0.080 |
Why?
|
| Tachycardia, Ventricular | 1 | 2009 | 19 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2009 | 25 | 0.080 |
Why?
|
| Cardiac Electrophysiology | 1 | 2008 | 2 | 0.080 |
Why?
|
| Iliac Vein | 1 | 2008 | 2 | 0.080 |
Why?
|
| Equipment Failure | 1 | 2008 | 35 | 0.080 |
Why?
|
| Pericardium | 1 | 2008 | 20 | 0.080 |
Why?
|
| Torsades de Pointes | 1 | 2007 | 7 | 0.070 |
Why?
|
| Long QT Syndrome | 1 | 2007 | 7 | 0.070 |
Why?
|
| Electrocardiography | 2 | 2022 | 91 | 0.070 |
Why?
|
| Amiodarone | 1 | 2005 | 3 | 0.060 |
Why?
|
| International Normalized Ratio | 1 | 2005 | 15 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 34 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2020 | 1618 | 0.060 |
Why?
|
| Warfarin | 1 | 2005 | 21 | 0.060 |
Why?
|
| Heart Conduction System | 1 | 2022 | 7 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 301 | 0.050 |
Why?
|
| Thermography | 1 | 2021 | 12 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 4508 | 0.050 |
Why?
|
| Temperature | 1 | 2021 | 60 | 0.050 |
Why?
|
| Swine | 1 | 2021 | 65 | 0.050 |
Why?
|
| Therapeutic Irrigation | 1 | 2021 | 50 | 0.050 |
Why?
|
| Sinoatrial Node | 1 | 2020 | 4 | 0.040 |
Why?
|
| Hyperthyroidism | 1 | 2020 | 12 | 0.040 |
Why?
|
| Heart Valve Diseases | 1 | 2020 | 14 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2020 | 10 | 0.040 |
Why?
|
| Lasers | 1 | 2020 | 16 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 142 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 275 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 40 | 0.040 |
Why?
|
| Alcoholism | 1 | 2020 | 65 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 42 | 0.040 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2020 | 59 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2020 | 140 | 0.040 |
Why?
|
| Hypertension | 1 | 2020 | 177 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 390 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 126 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 712 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 634 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 704 | 0.040 |
Why?
|
| Phlebography | 1 | 2017 | 9 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 291 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 24 | 0.040 |
Why?
|
| Myocardial Infarction | 2 | 2010 | 126 | 0.030 |
Why?
|
| Reoperation | 1 | 2020 | 847 | 0.030 |
Why?
|
| Animals | 1 | 2021 | 3430 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 450 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 48 | 0.020 |
Why?
|
| Epicardial Mapping | 1 | 2009 | 2 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2010 | 34 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 450 | 0.020 |
Why?
|
| Autopsy | 1 | 2010 | 317 | 0.020 |
Why?
|
| Hospitalization | 1 | 2010 | 284 | 0.020 |
Why?
|
| Chicago | 1 | 2010 | 916 | 0.020 |
Why?
|
| Adolescent | 1 | 2009 | 2018 | 0.010 |
Why?
|
| Length of Stay | 1 | 2005 | 295 | 0.010 |
Why?
|